Trinity Biotech (TRIB) Long-Term Investments (2017 - 2025)

Trinity Biotech's Long-Term Investments history runs 8 years deep, the most recent figure standing at $249000.0 for Q4 2025.

• In Q4 2025, Long-Term Investments fell 89.86% year-over-year to $249000.0; the TTM figure through Dec 2025 stood at $249000.0 (down 89.86% YoY), while the FY2025 annual figure was $249000.0, down 89.86% from the prior year.
• Long-Term Investments came in at $249000.0 for Q4 2025 at Trinity Biotech, down from $2.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $21.8 million in Q4 2021 to a low of $128000.0 in Q4 2022.
• A 5-year average of $5.4 million and a median of $2.6 million in 2024 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments tumbled 99.41% in 2022 and jumped 3723.44% in 2023, its largest moves.
• Trinity Biotech's Long-Term Investments stood at $21.8 million in 2021, then sank by 99.41% to $128000.0 in 2022, then surged by 3723.44% to $4.9 million in 2023, then slumped by 49.84% to $2.5 million in 2024, then plunged by 89.86% to $249000.0 in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $249000.0, $2.8 million, and $2.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison